Remove Chemotherapy Remove Labelling Remove Magazine
article thumbnail

J&J eyes prostate cancer label expansion for Akeega

Pharmaceutical Technology

Find out more J&J’s drug is an option for patients where medical or surgical treatment to lower testosterone levels has not worked, and in those who have BRCA 1/2 mutations – a subset of homologous recombination repair (HRR) mutations – in whom chemotherapy is not indicated.

article thumbnail

AstraZeneca’s Imfinzi approved in Europe for muscle-invasive bladder cancer

Pharmaceutical Technology

Imfinzi is now approved to treat adult patients with resectable muscle-invasive bladder cancer (MIBC) in combination with chemotherapy drugs gemcitabine and cisplatin as neoadjuvant treatment, and as a monotherapy after bladder removal surgery. Imfinzi is a major revenue driver for AstraZeneca, generating around $4.7bn in sales in 2024.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

SPuMoNI: Enhancing Pharma Data Quality through Smart Technologies

ISPE

Mexican Governor: Cancer Children Given Water Instead of Chemotherapy.” 3M explores New Label-As-A-Service Concept with Blockchain on Azure to Stop Counterfeit Pharmaceuticals.” 30 June 2016. link] 6 BBC News. Published 19 January 2017. link] 7 He, J., Cai, and X. IEEE Transactions on Signal Processing 68 (2020): 4069-82.

article thumbnail

GSK acquires efimosfermin alfa from Boston Pharma for $2bn

Pharmaceutical Technology

Go deeper with GlobalData Reports LOA and PTSR Model - Efbemalenograstim Alfa La in Chemotherapy Indu. Nominate Now Share Copy Link Share on X Share on Linkedin Share on Facebook Go deeper with GlobalData Reports LOA and PTSR Model - Efbemalenograstim Alfa La in Chemotherapy Indu. Find out more Sign up for our daily news round-up!